中新健康新闻:四款急需特医食品进入优先审评审批程序

中新网北京消息,国家市场监管总局日前宣布,针对临床急需的四种特殊医学用途配方食品(特医食品)已被纳入优先审评审批程序。这一决策将加快这些食品上市,为苯丙酮尿症、肾病和糖尿病患者等人群带来福音。

据了解,这四种特医食品是专为特定疾病患者设计,能够补充日常饮食中的营养素,帮助患者改善营养状况。此次纳入优先审评审批程序,意味着这些产品的审批流程将得到加速,以更快地满足市场需求。

国家市场监管总局表示,此举是为了更好地满足患者的营养需求,提高特殊医学用途配方食品的质量和安全性。此举将有助于改善患者的治疗效果和生活质量,进一步推动医疗健康事业的发展。

目前,这四款特医食品的具体信息尚未公布,但预计将很快面向市场,为广大患者带来福音。我们期待着这一重要举措能为患者带来更多的选择和希望。

英语如下:

News Title: “Priority Approval for Special Medical Formulated Foods: Accelerating the Pace for Treating Rare Diseases”

Keywords: Special medical food, Priority review, Disease application

News Content:
China Health News: Four Urgently Needed Special Medical Formulated Foods Enter Priority Review and Approval Process

Beijing, China News Service – The State Administration for Market Regulation (SAMR) recently announced that four types of formula foods for special medical purposes (special medical foods) that are urgently needed have been included in the priority review and approval process. This decision will speed up the launch of these foods and bring福音to people with phenylketonuria, kidney disease, diabetes, and other conditions.

It is understood that these four types of special medical foods are designed specifically for patients with certain diseases to supplement nutrients in their daily diet and help improve their nutritional status. Being included in the priority review and approval process means that the approval process for these products will be accelerated to meet market demand quickly.

SAMR stated that this action is taken to better meet the nutritional needs of patients and improve the quality and safety of formula foods for special medical purposes. This will help improve patients’ treatment outcomes and quality of life, further promoting the development of the healthcare industry.

Currently, the specific information of these four types of special medical foods has not been announced yet, but they are expected to be released to the market soon and bring福音 to a wide range of patients. We look forward to this important move providing patients with more options and hope.

【来源】http://www.chinanews.com/life/2024/07-02/10244351.shtml

Views: 2

发表回复

您的邮箱地址不会被公开。 必填项已用 * 标注